Acute pain the immune system and opioimmunosuppression

Acute Pain

Volumn 6, Issue 3-4, 2004, Pages 123-135

  Budd, Keith ^a   Shipton, E A ^b  

^a Newlands   (United Kingdom)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Acute pain; Immune system; Opioids; Opioimmunosuppression

Indexed keywords

CYTOKINE; OPIATE;

B LYMPHOCYTE; CLINICAL FEATURE; GLIA CELL; HUMAN; IMMUNE FUNCTION TEST; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PAIN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 12744279459     PISSN: 13660071     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acpain.2004.08.003     Document Type: Review

References (132)

1. H.F. Galley, and N.R. Webster The immuno-inflammatory cascade Br J Anaesth 77 1996 11 16
2. F.Q. Cunha, and S.H. Ferreira Peripheral hyperalgesic cytokines H. Machelska C. Stein Immune mechanisms of pain and analgesia 2001 Kluwer Academic New York 22 39
3. L.S. Gazda, E.D. Milligan, M.K. Hansen, C.M. Twining, M. Paulos, and M. Charcur Sciatic inflammatory neuritis (SIN): behavioural allodynia is paralleled by peri-sciatic proinflammatory cytokine and superoxide production J Peripheral Nerv Syst 6 2001 111 129
4. E. Weihe, M. Buchler, S. Muller, H. Friess, H.J. Zentel, and N. Yanaihara Peptidergic innervation in chronic pancreatitis H.G. Berger M. Buchler H. Ditschuneit P. Malfertheiner Chronic pancreatitis 1990 Springer Berlin 83 105
5. C.M. Twining, E.M. Sloane, E.D. Mulligan, M. Chacur, D. Martin, and S. Poole Peri-sciatic proinflammatory cytokines, reactive oxygen species and complement induce mirror image neuropathic pain in rats Pain 110 2004 99 309
6. J.A. DeLeo, F.Y. Tanga, and V.L. Tawfik Neuroimmune activaton and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia Neuroscientist 10 1 2004 40 52
7. A. Dray, and P. Beavan Inflammation and hyperalgesia; highlighting the team effort TIPS 14 1993 287 290
8. K.S. Vikman, R.H. Hill, E. Backstrom, B. Robertson, and K. Kristensson Interferon-γ inducescharacteristics of central sensitization in spinal dorsal horn neurons in vitro Pain 106 2001 241 251
9. R.J. Weber, B. Ikejiri, and K.C. Rice Opiate receptor mediated regulation of the immune response in vivo NIDA Res Mono 36 1987 341 348
10. W. Janson, and C. Stein Peripheral opioid analgesia Curr Pharm Biotechnol 4 4 2003 270 274
11. A. Menzebach, J. Hirsch, G. Hempelmann, and I.D. Welters Effects of enogenous and synthetic opioid peptides on neutrophil function in vitro Br J Anaesth 91 2003 546 550
12. H. Machelska, M. Schafer, L. Carter, and C. Stein Interleukin 1-β and corticotrophin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue Proc Natl Acad Sci USA 91 1994 4219 4223
13. J. Gehrmann, S. Monaco, and G.W. Kreutzberg Spinal cord microglial cells and DRG satellite cells rapidly respond to transection of the rat sciatic nerve Restorative Neurol Neurosci 2 1991 181 198
14. C.J. Garrison, P.M. Dougherty, and K.C. Kajander Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following sciatic nerve constriction injury Brain Res 565 1991 1 7
15. C.J. Garrison, P.M. Dougherty, and S.M. Carlton GFAP expression in lumber spinal cord of naive and neuropathic rats treated with MK801 Exp Neurol 129 1994 237 243
16. L.R. Watkins, and S.F. Maier The pain of being sick; implications of immune-to-brain communication for understanding pain Ann Rev Psychol 1 2000 29 57
17. S.M. Sweitzer, P. Schbert, and J.A. DeLeo Propentofylline, a glial modulating agent, exhibits anti-allodynic properties in a rat model of neuropathic pain J Pharmacol Exp Ther 297 2001 1210 1217
18. E.D. Milligan, K. Mehmert, and J.L. Hindle Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 envelope glycoprotein, gp120 Brain Res 861 2000 105 116
19. L.R. Watkins, E.D. Milligan, and S.F. Maier Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain H. Machelska C. Stein Immune mechanisms of pain and analgesia 2003 Kluwer Academic New York 1 21
20. W.J. Sandborn, and S.B. Hanauer Antitumour necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results and safety Inflamm Bowel Dis 5 1999 119 133
21. L.G. Corral, G.W. Muller, and A.L. Moreira Selection of novel analogues of thalidomide with enhanced tumour necrosis alpha inhibitory activity Mol Med 2 1996 506 515
22. K. Zwingenberger, and S. Wnendt Immunomodulation by thalidomide: systemic review of the literature and of unpublished observations J Inflamm 46 1995 177 211
23. R. Gallily, M. Kipper-Galperin, and T. Brenner Mycoplasma fermentans-induced inflammatory response of astrocytes: selective modulation by amnoguanidine, thalidomide, pentoxifylline and IL-10 Inflammation 23 1999 495 505
24. P.K. Peterson, S. Hu, and W.S. Sheng Thalidomide inhibits tumor necrosis factor-alpha production by lipopolysaccharide- and lipoarabinomannan-stimulated human microglial cells J Infect Dis 172 1995 1137 1140
25. A. George, M. Marziniak, and M. Schäfers Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-alpha, increases interlukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin Pain 88 2000 267 275
26. C. Sommer, C. Schmidt, and A. George A metalloprotease-inhibitor reduces pain associated behaviour in mice with experimental neuropathy Neurosci Lett 237 1997 45 48
27. W.B. Weglicki, R.E. Stafford, and B.F. Dickens Inhibition of tumor necrosis factor-alpha by thalidomide in magnesium deficiency Mol Cell Biochem 129 1993 195 200
28. RJ. Flower, and NJ. Rothwell Lipocortin-1: cellular mechanisms and clinical relevance Trends Pharmacol Sci 15 1994 71 76
29. M. Perretti, A. Ahluwalia, and JG. Harris Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse. A qualitative comparison with an anti-CD11b monoclonal antibody J Immunol 151 1993 4306 4314
30. F.Q. Cunha, and S.H. Ferreira Peripheral hyperalgesic cytokines H. Machelska C. Stein Immune mechanisms of pain and analgesia 2001 Kluwer Academic New York 22 35
31. B. Hassel, R.E. Paulsen, and A. Johnson Selective inhibition of glial cell metabolism by fluorocitrate Brain Res 249 1992 120 124
32. T.R. Mosman, and S. Sad The expanding universe of T-cell subsets: Th1, Th2 and more Immunol Today 17 1998 138 146
33. S. Roy, J. Wang, R. Charboneau, H.H. Loh, and R.A. Brake Chronic morphine treatment differentiates T helper cells to Th2 effector cells by modulating transcription factors GATA 3 and T-bet J Neuroimmunol 2004 147
34. S.T. Holgate The epidemic of asthma and allergy J R Soc Med 97 2004 103 110
35. D.T. Krieger Brain peptides: what, where and why? Science 222 1983 975 985
36. J. Wybran, T. Appleboom, and J.P. Famacy Suggestive evidence for receptors for morphine and methionine enkephalin on normal blood T lymphocytes J Immunol 123 1979 1068 1070
37. M.R. Hutchinson, S.F. La Vinccente, and A.A. Somogyi In vitro opioid induced proliferation of peripheral blood immune cells correlates with in vivo pressor pain tolerance in humans: a biological marker of pain tolerance Pain 110 2004 751 755
38. A.E. Panerai, and P. Sacerdote Beta-endorphin in the immune system: a role at last Immunol Today 18 1997 317 319
39. P. Sacerdote, E. Limiroli, and L. Gaspani Experimental evidence for immunomodulator effects of opioids H. Machelska C. Stein Immune mechanisms of pain and analgesia 2001 Kluwer Academic New York 106 116
40. N.C. Alonzo, and B.M. Bayer Antagonism of N-methyl-d-aspartate receptors reduces the vulnerability of the immune system to stress after chronic morphine J Pharmacol Exp Ther 302 2003 793 800
41. P.E. Molina, K.L. Zambell, P. Zhang, C. Van de Stouwe, and J. Carnal Hemodynamic and immune consequences of opiate analgesia after trauma/hemorrhage Shock 21 2004 204 211
42. P. Sacerdote, M. Bianchi, L. Gaspani, B. Manfredi, A. Maucione, and G. Terno The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients Anesth Analg 90 2000 1411 1414
43. J.D. Sapira The heroin addict as a medical patient Am J Med 45 1968 555 558
44. J. Kutza, J. Gratz, and M. Ashfar The effects of general anaesthesia and surgery on basal and interoperative natural killer cell activity Arch Surg 126 1991 338 342
45. R.E. Pollock, E. Letzova, and S.D. Stanford Mechanism of surgical stress impairment of human perioperative natural killer cell cytotoxicity Arch Surg 126 1991 338 342
46. N.K. Ellis, G.P. Duffie, and M.R. Young The effects of 16,16-dimethyl PGE2 and phosphodiesterase inhibitors on Con A blastogenic responses and NK cytotoxic activity of mouse spleen cells J Leukoc Biol 47 1990 371 377
47. J.M. Risdahl, K.U. Khanna, and K.W. Peterson Opiates and infections J Neuroimmunol 83 1998 4 18
48. A.E. Le Cras, H.F. Galley, and N.R. Webster Spinal but not general anaesthesia increases the ratio of T helper-1 to T helper-2 cell subsets in patients undergoing transurethral resection of prostate Anesth Analg 87 1998 142 145
49. D. Decker, M. Schondorf, and F. Bidlingmaier Surgical stress induces a shift in the type 1/type 2 T-helper cell balance, suggesting down-regulation of cell mediated and up-regulation of antibody-mediated immunity commensurate to trauma Surgery 119 1998 457 463
50. P. Ryhannen Effects of anaesthesia and operative surgery on the immune response of patients of different ages Ann Clin Res 9 1977 19
51. J. Rem, M.R. Brandt, and H. Kehlet Prevention of postoperative lymphopaenia and granulocytosis by epidural analgesia Lancet I 1980 283 285
52. M. Salo Effect of anaesthesia and open heart surgery on lymphocyte responses to phytohaemagglutinin concavalin-A Acta Anaesthesiol Scand 229 1978 471 479
53. M.C. Berenbaum, P.A. Fluck, and N.P. Hurst Depression of lymphocyte response after surgical trauma Br J Exp Pathol 53 1973 597 607
54. M. Paroli, M. Biffoni, and P. Falaschi Effects of exogenous opioids on natural killer cell activity in vivo J Endocrinol Invest 12 1989 61 66
55. E. Tonnesen, H. Mickley, and N. Grunnet Natural killer cell activity during premedication, anaesthesia and surgery Acta Anaesth Scand 27 1983 233 241
56. D.B. Louria, T. Hensle, and J. Rose The major medical complications of heroin addiction Ann Int Med 67 1967 1 4
57. D. Decker, M. Schondorf, and F. Bidlingmaier Surgical stress induces a shift in the type1/type2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to trauma Surgery 119 1996 316 325
58. E.B. Riboli, A. Terrizzi, and G. Arnulfo Immunosuppressive effect of surgery evaluated by the multitest cell-meduated immunity system Can J Surg 27 1984 60 63
59. L.C. Band, A. Pert, and W. Williams Central mu opioid receptors mediate suppression of natural killer cell activity in vivo Prog Neuroendocrinol 5 1992 95
60. W.A. Koltun, M.M. Bloomer, and A.F. Pilberg Awake epidural anaesthesia is associated with improved natural killer cell cytotoxicity and reduced stress response Am J Surg 171 1996 6 73
61. E. Tonnesen, and C. Wahlgren Influence of extradural and general anaesthesia on natural killer cell activity and lymphocyte subpopulations in patients undergoing hysterectomy Br J Anaesth 60 1988 500 507
62. M.P. Yeager, D.D. Glass, and R.K. Neff Epidural anaesthesia and analgesia in high risk surgical patients Anesthesiology 66 1987 729 736
63. D.A. Papanicolaou, R. Wilder, and S.C. Monoglas The pathophysiologic roles of interleukin 6 in human disease Ann Int Med 128 1998 127 137
64. GG. Page The immune-suppressive effects of pain H. Machelska C. Stein Immune mechanisms of pain and analgesia 2003 Kluwer Academic New York 117 125
65. J.P. Portanova, Y. Zhang, and G.B. Anderson Selective neutralisation of prostaglandin E-2 blocks inflammation, hyperalgesia and interleukin-6 production in vivo J Exp Med 184 1996 883 891
66. C. Chambrier, D. Chassard, and J. Bienvenue Cytokine and hormonal changes after cholecystectomy. Effect of ibuprofen treatment Ann Surg 224 1996 178 182
67. G.D. Anderson, S.D. Hauser, and K.L. McGarity Selective inhibition of cyclo-oxygenase (COX-2) reverses inflammation and expression of COX-2 interleukin-6 in rat adjuvant arthritis J Clin Invest 97 1996 2672 2679
68. P.J. Cabot, L. Carter, and C. Gaiddon Immune cell derived β-endorphin. Production, release and control of inflammatory pain in rats J Clin Invest 100 1997 142 148
69. D.S. Jessop Neuropeptides: modulators of the immune system Curr Opin Endocrinol Diab 5 1998 52 58
70. D.J.J. Carr, T.J. Rogers, and R.J. Weber The release of opioids and opioid receptors on immunocompetence and immune homeostasis Proc Soc Exp Biol Med 213 1996 248 257
71. H. Hussey, and S. Katz Infections resulting from narcotic addiction: report of 102 cases Am Med J 9 1950 186 189
72. S.J. Schocaht, C.A. Miuer, and P. Snyder Evaluation of cellular immunity and adrenocortical activity in surgical patients J Surg Res 26 1979 332 340
73. L. McCarthy, M. Wetzel, J.K. Sliker, T.K. Eisenstein, and T.J. Rogers Opioids, opioid receptors and the immune response Drug Alcohol Depend 62 2001 111 123
74. G. Wei, J. Moss, and C.S. Yuan Opioid-induced immunosupression: is it centrally mediated or peripherally mediated? Biochem Pharmacol 65 2003 1761 1766
75. J.M. Risdahl, K.U. Khanna, and K.W. Peterson Opiates and infections J Neuroimmunol 83 1998 4 18
76. J.W. Lewis, Y. Shavit, and G.W. Terman Stress and morphine affect survival of rats challenged with mammary ascites tumour (MAT 13762B) Nat Immun Cell Growth Regul 3 1983 43 50
77. M.P. Yeager, T.A. Colacchio, and C.T. Yu Morphine inhibits spontaneous and cytokine enhanced natural killer cell cytotoxicity in volunteers Anesthesiology 83 1995 500 508
78. D.M. Hall, J.-L. Suo, and R.J. Weber Opioid mediated effects on the immune system: sympathetic nervous system involvement J Neuroimmunol 83 1998 29 35
79. K. Beageles, A. Wallenstein, and B. Bayer Systemic morphine administration suppresses genes involved in antigen presentation Mol Pharmacol 65 2004 437 442
80. A. Menzebach, J. Hirsch, R. Nost, M. Mogk, and G. Hempelmann Morphine inhibits complement receptor receptor expression, phagocytosis and oxidative burst by a nitric oxide dependent mechanism Anasthesiol Intensivmed Notfallmed Schmerzther. 39 2004 204 211
81. S. Roy, S. Ramakrishnan, and H.H. Loh Chronic morphine treatment selectively suppresses macrophage colony formation in bone marrow Eur J Pharmacol 195 1991 359 363
82. E. Faist, W. Ertel, and T. Cohnert Immunoprotective effects of cyclo-oxygenase inhibition in patients with major surgical trauma J Trauma 30 1990 8 18
83. E. Tubaro, C. Santiangeli, and I. Bekogi Methadone v morphine: comparison of their effect on phagocytic functions Int J Immunopharmacol 9 1987 79 88
84. M. Rojavin, I. Szabo, and J.L. Bussiere Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages Life Sci 53 1993 997 1006
85. S. Roy, R.G. Charboneau, and R.A. Barke Morphine synergism with lipopolysaccharide in a chronic endotoxaemia model J Neuroimmunomod 95 1999 107 114
86. I.A. Casalinuovo, R. Graziano, and P. Di Francesco Cytokine secretion by murine spleen cells after inactivated Candida albicans immunization. Effect of cocaine and morphine treatment Immunopharmacol Immunotoxicol 22 2000 35 48
87. R. Pacifici, S. Di Carlos, and A. Bacosi Pharmacokinetics and cytokine production in heroin and morphine treated mice J Immunopharmacol 22 2000 603 614
88. D.T. Lsyle, M.E. Coussons, and V.J. Watts Morphine induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone J Pharmacol Exp Ther 265 1993 1071 1078
89. D.J.J. Carr, B.M. Gebhart, and D. Paul α-Adrenergic and IL-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer cell activity J Pharmacol Exp Ther 264 1993 1179 1186
90. D.J.J. Carr, L.R. Gerak, and C.P. France Naltrexone antagonises the analgesic and immunosuppressive effects of morphine in mice J Pharmacol Exp Ther 269 1994 693 698
91. N.K. Ellis, G.P. Duffie, and M.R. Young The effects of 16,16-dimethyl PGE2 and phosphodiesterase inhibitors on Con A blastogenic responses and NK cytotoxic activity of mouse spleen cells J Leukoc Biol 47 1990 371 377
92. D.T. Lsyle, K.E. Hoffman, and L.A. Dykstra Evidence for the involvement of the caudal region of the periaqueductal grey in a subset of morphine-induced alterations of immune status J Pharmacol Exp Ther 277 1996 1535 1540
93. B.M. Bayer, S. Daussin, and M. Hernandez Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism Neuropharmacology 29 1990 369 374
94. L.R. Flores, K.L. Dretchen, and F.C. Martin Potential role of the autonomic nervous system in the immunosuppressive effects of acute morphine administration Eur J Pharmacol 318 1996 437 446
95. H.U. Bryant, and R.E. Roudebush Suppressive effects of morphine pellet implants on in vivo parameters of immune function J Pharmacol Exp Ther 255 1990 41
96. T.K. Eisnestein, and M.E. Hillburger Opioid modulation of immune responses: effects on phagocyte and lymphoid populations J Neuroimmunol 83 1998 36 44
97. D.O. Frier, and B.A. Fuchs A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of NK cell activity J Pharmacol Exp Ther 270 1994 1127 1133
98. L.R. Flores, and R.J. Webster Opioids, opioid receptors and the immune system P. Plotnikoff J.A. Firth M. Murgo F. Good Cytokines, stress and immunity 1999 CRC Press London 281 314
99. C. Gaveriaux-Ruff, H.W.D. Matthes, and J. Peluso Abolition of morphine-immunosuppression in mice lacking the mu opioid receptor gene Proc Natl Acad Sci USA 95 1998 6326 6328
100. Y. Shavit, J.W. Lewis, and G.W. Terman Opioid peptides mediate the suppressive effect of stress on natural killer cell toxicity Science 223 1984 188 190
101. R.D. Melon, and B.M. Bayer Evidence for central opioid receptors in the immunomodulatory effects of morphine: review of potential mechanism(s) of action J Neuroimmunol 83 1998 19 28
102. V. Blahoutova, A. Zajicova, H. Wilczek, and V. Holan Opioids and their immunomodulatory properties Cas Lek Cesk. 142 2003 244 247
103. L.R. Flores, M.C. Hernandez, and B.M. Bayer Acute immunosuppressive effects of morphine: lack of involvement of pituitary and adrenal factors J Pharmacol Exp Ther 268 1994 1129 1134
104. D.J.J. Carr, S. Mayo, and B.M. Gebhardt Central alpha-adrenergic involvement in morphine mediated suppression of splenic natural killer cell activity J Neuroimmunol 53 1994 53 63
105. R.J. Weber, and A. Peart The periaqueductal gray matter mediates opiate-induced immunosuppression Science 245 1989 188 190
106. J. Wang, R. Charboneau, S. Balasubramian, R.A. Barke, H.H. Loh, and S. Roy The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the mu opioid receptor J Leukoc Biol 71 2002 782 790
107. K. Fecho, K.A. Maslonek, and L.A. Dykstra Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats J Pharmacol Exp Ther 276 1996 626 636
108. G.B. Stefano, B. Salzet, and C.M. Rialas Morphine- and anandamide-stimulated nitric oxide production inhibits presynaptic dopamine release Brain Res Dev Brain Res 763 1997 63 68
109. J.-L. Suo, and R.J. Weber Immunosuppression following PAG morphine injection is correlated with activation of the HPA axis and is not blocked by mifepristone H. Friedman J. Madden T. Klein Drugs of abuse, immunomodulation and AIDS 1988 Plenum Press New York 126 148
110. D.J.J. Carr, and G.W. Carpenter Morphine-induced suppression of cytotoxic T-lymphocyte activity in alloimmunized mice is not mediated through a naltrindole-sensitive delta opioid receptor Neuroimmunomodulation 2 1995 44
111. M. Scott, and D.J.J. Carr Morphine suppresses the alloantigen CTL response in a dose dependent and naltrexone reversible manner J Pharmacol Exp Ther 278 1996 980 988
112. E. Tubaro, G. Borelli, and C. Croce effect of morphine on resistance to infection J Infect Dis 48 1983 656 666
113. D.M. Novick, M. Ochshor, and V. Ghali Natural killer activity and lymphocyte sub-sets in parenteral heroin abusers and long term methadone maintenance patients J Pharmacol Exp Ther 250 1989 606 610
114. M. Starec, B. Rouveix, and M. Sinet Immune status and survival of opiate and cocaine treated mice infected with Friend virus J Pharmacol Exp Ther 259 1991 745 750
115. C.C. Chao, B.M. Sharp, and C. Pomeroy Lethality of morphine in mice infected with Toxoplama gondii J Pharmacol Exp Ther 252 1990 605 609
116. B. Beilin, F.C. Martin, and Y. Shavit Suppression of natural killer cell activity by high dose narcotic anesthesia in rats Brain Behav Immunol 3 1989 129 137
117. D.J.J. Carr, M.L. Baker, and C. Holmes OLM3292: a fentanyl-related 4-heteroanilidopiperidine with analgesic but no suppressive effects on splenic NK activity in mice Int J Immunol 16 1994 835 844
118. P. Sacerdote, L. Gaspani, G. Rossoni, A.E. Panerai, and M. Bianchi Effect of the opioid remifentanil on cellular immune response in the rat Int Immunopharmacol 1 2001 713 719
119. P. Sacerdote, B. Manfredi, and P. Mantegazza Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study Br J Pharmacol 121 1997 834 840
120. P. Sacerdote, B. Manfredi, L. Gaspani, and A.E. Panerai The opioid antagonist naloxone induces a shift from type 1 cytokine pattern to type 2 cytokine pattern in BALB/Jmice Blood 95 2000 782 790
121. S. Palm, T. Magnar, and K. Kuhn Phytohaemagglutinin-dependent T-cell proliferation is not impaired by morphine Methods Find Exp Clin Pharmacol 18 1996 159 165
122. G.W. Carpenter, L. Breeden, and D.J.J. Carr Acute exposure to morphine suppresses cytotoxic T-lymphocyte activity Int J Immunopharmacol 17 1995 1001 1016
123. C. Mantucci, A.E. Panerai, and P. Sacerdote Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses Pain 110 2004 385 392
124. W. Williams, K.C. Rice, and R.J. Weber Non-peptide opioids: in vivo effects on the immune system NIDA Res Mono 105 1991 404 407
125. H. Van Loveren, N. Gianotten, C.F.M. Hendriksen, H.J. Schuurman, and J.W. Van Der Laan Assessment of immunotoxicity of buprenorphine Lab Anim 28 1994 355 363
126. N. Jobin, D.R. Garrel, and J. Bernier Increased burn-induced immunosuppression in lipopolysaccharide resistant mice Cell Immunol 200 2000 65 75
127. M. D'Elia, J. Patenaude, C. Hamelin, D.R. Garrel, and J. Bernier No detrimental effect from the chronic exposure to buprenorphine on corticosteroid-binding globulin and corticosensitive immune parameters Clin Immunol 109 2003 179 187
128. R. Mossner, and K.P. Lesoh Role of serotonin in the immune system and in neuroimmune interactions Brain Behav Immun 12 1988 249 271
129. S. Liunat, S.Y. Felton, and S.L. Carlsden Involvement of perihperal and central catecholamine systems in neural-immune interactions J Neuroimmunol 10 1985 5 10
130. P. Sacerdote, M. Bianchi, and L. Gaspani Effects of tramadol and its enantiomers on concavalin-A induced proliferation and NK activity of mouse splenocytes: involvement of serotonin Int J Immunopharmacol 21 1999 727 734
131. Y.-C. Tsai, and S.-J. Won Effects of tramadol on T-lymphocyte proliferation and natural killer cell activity in rats with sciatic constriction injury Pain 92 2001 63 69
132. P. Sacerdote, M. Bianchi, B. Manfredi, and A. Paneri Effects of tramadol on immune responses and nociceptive thresholds in mice Pain 72 1997 325 330